Quantinno Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.4M Buy
370,518
+48,829
+15% +$2.65M 0.03% 609
2025
Q4
$15.8M Buy
321,689
+71,471
+29% +$3.33M 0.03% 608
2025
Q3
$10.8M Buy
250,218
+61,125
+32% +$2.39M 0.03% 636
2025
Q2
$7.26M Buy
189,093
+61,358
+48% +$2.34M 0.03% 660
2025
Q1
$4.95M Buy
127,735
+20,982
+20% +$768K 0.03% 655
2024
Q4
$3.61M Buy
106,753
+6,948
+7% +$250K 0.04% 611
2024
Q3
$4.08M Sell
99,805
-2,880
-3% -$118K 0.05% 449
2024
Q2
$3.95M Buy
102,685
+8,041
+8% +$338K 0.07% 321
2024
Q1
$4.06M Buy
94,644
+10,642
+13% +$439K 0.09% 256
2023
Q4
$3.11M Buy
84,002
+17,792
+27% +$639K 0.11% 227
2023
Q3
$2.4M Buy
66,210
+49,367
+293% +$1.75M 0.11% 234
2023
Q2
$600K Buy
16,843
+3,211
+24% +$115K 0.03% 576
2023
Q1
$485K Buy
13,632
+1,515
+13% +$53K 0.03% 585
2022
Q4
$426K Buy
+12,117
New +$404K 0.03% 583

Other funds holding GSK